These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27474493)

  • 21. A patient with Crimean-Congo hemorrhagic fever serologically diagnosed by recombinant nucleoprotein-based antibody detection systems.
    Tang Q; Saijo M; Zhang Y; Asiguma M; Tianshu D; Han L; Shimayi B; Maeda A; Kurane I; Morikawa S
    Clin Diagn Lab Immunol; 2003 May; 10(3):489-91. PubMed ID: 12738657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and applications of a Crimean-Congo hemorrhagic fever virus nucleoprotein-specific Affimer: Inhibitory effects in viral replication and development of colorimetric diagnostic tests.
    Álvarez-Rodríguez B; Tiede C; Hoste ACR; Surtees RA; Trinh CH; Slack GS; Chamberlain J; Hewson R; Fresco A; Sastre P; Tomlinson DC; Millner PA; Edwards TA; Barr JN
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008364. PubMed ID: 32492018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies.
    Gülce-İz S; Elaldı N; Can H; Şahar EA; Karakavuk M; Gül A; Kumoğlu GÖ; Döşkaya AD; Gürüz AY; Özdarendeli A; Felgner PL; Davies H; Döşkaya M
    Sci Rep; 2021 Mar; 11(1):5936. PubMed ID: 33723328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and characterization of soluble recombinant Crimean-Congo hemorrhagic fever virus glycoprotein Gc expressed in mammalian 293F cells.
    Makoah NA; Litabe MM; Simo FBN; Maboho KK; Burt FJ
    BMC Biotechnol; 2024 Aug; 24(1):59. PubMed ID: 39192233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Multispecies Recombinant Nucleoprotein-Based Indirect ELISA for High-Throughput Screening of Crimean-Congo Hemorrhagic Fever Virus-Specific Antibodies.
    Shrivastava N; Shrivastava A; Ninawe SM; Sharma S; Kumar JS; Alam SI; Kanani A; Sharma SK; Dash PK
    Front Microbiol; 2019; 10():1822. PubMed ID: 31507540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].
    Uyar Y; Carhan A; Albayrak N; Altaş AB
    Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of double antibody sandwich ELISA as potential diagnostic tool for rapid detection of Crimean-Congo hemorrhagic fever virus.
    Shrivastava N; Kumar JS; Yadav P; Shete AM; Jain R; Shrivastava A; Dash PK
    Sci Rep; 2021 Jul; 11(1):14699. PubMed ID: 34282163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulation of Crimean-Congo Hemorrhagic Fever Virus in the former Yugoslav Republic of Macedonia revealed by screening of cattle sera using a novel enzyme-linked immunosorbent assay.
    Mertens M; Vatansever Z; Mrenoshki S; Krstevski K; Stefanovska J; Djadjovski I; Cvetkovikj I; Farkas R; Schuster I; Donnet F; Comtet L; Tordo N; Ben Mechlia M; Balkema-Buschmann A; Mitrov D; Groschup MH
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003519. PubMed ID: 25742017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Crimean-Congo Hemorrhagic Fever Orthonairovirus AviTagged Nucleoprotein for Potential Application in Diagnosis.
    Jalali T; Salehi-Vaziri M; Pouriayevali MH; Mousavi Gargari SL
    Iran Biomed J; 2019 Nov; 23(6):379-87. PubMed ID: 31104398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV).
    Liu D; Li Y; Zhao J; Deng F; Duan X; Kou C; Wu T; Li Y; Wang Y; Ma J; Yang J; Hu Z; Zhang F; Zhang Y; Sun S
    PLoS One; 2014; 9(11):e108419. PubMed ID: 25365026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin-like Domain of
    Rackow A; Ehmen C; von Possel R; Medialdea-Carrera R; Brown D; Bispo de Filippis AM; Carvalho de Sequeira P; Ribeiro Nogueira RM; Halili B; Jakupi X; Berisha L; Ahmeti S; Sherifi K; Schmidt-Chanasit J; Schmitz H; Mika A; Emmerich P; Deschermeier C
    Clin Chem; 2019 Mar; 65(3):451-461. PubMed ID: 30709812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroepidemiological and molecular investigations of infections with Crimean-Congo haemorrhagic fever virus in Kazakhstan.
    Abdiyeva K; Turebekov N; Dmitrovsky A; Tukhanova N; Shin A; Yeraliyeva L; Heinrich N; Hoelscher M; Yegemberdiyeva R; Shapiyeva Z; Kachiyeva Z; Zhalmagambetova A; Montag J; Dobler G; Zinner J; Wagner E; Frey S; Essbauer S
    Int J Infect Dis; 2019 Jan; 78():121-127. PubMed ID: 30522982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of human antibodies to Crimean-Congo haemorrhagic fever virus using expressed viral nucleocapsid protein.
    Marriott AC; Polyzoni T; Antoniadis A; Nuttall PA
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2157-61. PubMed ID: 8077915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First serological evidence of Crimean-Congo haemorrhagic fever in febrile patients in Mozambique.
    Muianga AF; Watson R; Varghese A; Chongo IS; Ali S; Monteiro V; Inalda F; Chelene I; António V; Hewson R; Gudo ES
    Int J Infect Dis; 2017 Sep; 62():119-123. PubMed ID: 28782604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.
    Saijo M; Georges-Courbot MC; Marianneau P; Romanowski V; Fukushi S; Mizutani T; Georges AJ; Kurata T; Kurane I; Morikawa S
    Clin Vaccine Immunol; 2007 Sep; 14(9):1182-9. PubMed ID: 17634509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of anti-Crimean-Congo hemorrhagic fever virus Gc and NP-specific ELISA for detection of antibodies in domestic animal sera.
    Belij-Rammerstorfer S; Limon G; Maze EA; Hannant K; Hughes E; Tchakarova SR; Alexandrov T; Mmbaga BT; Willett B; Booth G; Lyons NA; Baker N; Thomas KM; Wright D; Saunders J; Browning C; Wilsden G; Carroll M; Hewson R; Charleston B; Lambe T; Ludi AB
    Front Vet Sci; 2022; 9():913046. PubMed ID: 36090164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serosurvey of Crimean-Congo hemorrhagic fever virus in domestic animals, Gujarat, India, 2013.
    Mourya DT; Yadav PD; Shete A; Majumdar TD; Kanani A; Kapadia D; Chandra V; Kachhiapatel AJ; Joshi PT; Upadhyay KJ; Dave P; Raval D
    Vector Borne Zoonotic Dis; 2014 Sep; 14(9):690-2. PubMed ID: 25229708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evaluation of indirect antibody ELISA assay for early diagnosis and surveillance of Crimean-Congo hemorrhagic fever infection in humans.
    Shrivastava N; Kumar JS; Yadav P; Sharma S; Shete AM; Jain R; Shrivastava A; Dash PK
    Virus Res; 2022 May; 313():198717. PubMed ID: 35189158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.
    Kempster S; Hassall M; Graham V; Kennedy E; Findlay-Wilson S; Salguero FJ; Bagci B; Elaldi N; Oz M; Tasseten T; Charlton FW; Barr JN; Fontana J; Duru C; Ezeajughi E; Matejtschuk P; Arnold U; Adedeji Y; Mirazimi A; Hewson R; Dowall S; Almond N
    Virus Res; 2024 Aug; 346():199409. PubMed ID: 38815869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroepidemiological study of Crimean-Congo haemorrhagic fever in Greece, 2009-2010.
    Sidira P; Maltezou HC; Haidich AB; Papa A
    Clin Microbiol Infect; 2012 Feb; 18(2):E16-9. PubMed ID: 22192082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.